Year: 2026
Type: article
Abstract: Tristan J. Barber has received speaker fees, advisory board honoraria, and educational/research grants from Gilead, Johnson and Johnson, Merck/MSD, NovoNordisk, Roche, and ViiV/GSK. Marta Boffito has received speaker fees, advisory board honoraria, and educational/research grants (to the organization) from ViiV/GSK, Merck Sharp & Dohme, Gilead, Pfizer, Sanofi, Moderna. Yvonne Gilleece has received bursaries for educational meetings and advisory boards from ViiV, MSD, Janssen, and Gilead. Portia Jackson nil received. Nadia Naous nil received. Michael Rayment has received advisory board honoraria from GSK. Iain Reeves has received speaker fees and advisory board honoraria from ViiV Healthcare, MSD pharmaceuticals, and Gilead Sciences. Amanda Samarawickrama nil received. Caroline Sabin has received funding for the provision of educational materials and for participation in advisory panels for Gilead Sciences, ViiV Healthcare, and MSD. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Source: HIV Medicine
DOI: 10.1111/hiv.70302
Institutions: Royal Free London NHS Foundation Trust, University College London, Chelsea and Westminster Hospital NHS Foundation Trust, Brighton and Sussex Medical School, University Hospitals Sussex NHS Foundation Trust, Cambridgeshire Community Services NHS Trust, Homerton University Hospital NHS Foundation Trust, University Hospitals Plymouth NHS Trust
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7204164834